2017年5月31日星期三

Engineered mutation of some important amino acids in angiotensin II type 1 (AT1) receptor increases the binding affinity of AT1-receptor antagonists

Engineered mutation of some important amino acids in angiotensin II type 1 (AT1) receptor increases the binding affinity of AT1-receptor antagonists

MA Bhuiyan, M Hossain, M Ishiguro… - Journal of …, 2010 - jstage.jst.go.jp
... software. Statistical analyses were performed by Stu- dent's t-test. Drugs Ang II used
in the study was purchased from Peptide Institute, Inc., Osaka. Candesartan was
obtained as gift from Takeda Chemical Industries Ltd., Osaka. ...


Peptide synthesis, peptide modification and peptide library synthesis, please contact:
Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com

没有评论:

发表评论